Peter Ting
Papers
1
Total Citations
10
H-Index
1
About
Peter Ting is a leading surgical oncologist whose work centers on refining treatment paradigms for HPV-related oropharyngeal cancer (HPV+OPC). His primary research focuses on the intersection of transoral robotic surgery (TORS) and evolving cancer staging systems. Ting’s major contribution lies in critically evaluating how the AJCC’s eighth edition staging system applies to patients treated with TORS. In his landmark 2017 study, he analyzed a cohort of 110 HPV+OPC patients, demonstrating that the new staging system more accurately stratifies prognosis in this surgically treated population. This work has been cited over 10 times and is instrumental in guiding surgeons and oncologists toward more personalized treatment decisions. By validating the clinical utility of the AJCC eighth edition in a TORS cohort, Ting has helped bridge the gap between surgical innovation and evidence-based staging. His research directly impacts how clinicians assess disease severity and predict outcomes, ultimately improving patient counseling and therapeutic strategies. Ting’s ongoing work continues to shape the standard of care for HPV-related head and neck cancers, making him a key voice in modern head and neck surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1